Search Medical Condition
Please enter condition
Please choose location from dropdown
 

One Or Multiple Investigational Sites, Japan Clinical Trials

A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (56710) clinical trials

Do you suffer from moderate to severe Crohn’s disease? If so, you may qualify for a clinical trial. ClinSearch is testing the safety and effectiveness of an investigational medication for individuals with moderate to severe Crohn’s disease.

Phase N/A

Friedreich's ataxia is an autosomal recessive cerebellar ataxia caused by triplet-repeat expansions. The causative mutation is a trinucleotide (GAA) repeat expansion in the first intron of the frataxin gene, leading to impaired transcription of frataxin. The pathological consequences of frataxin deficiency include a severe disruption of iron-sulfur cluster biosynthesis, mitochondrial ...

Phase

If you’ve been unable to control your blood pressure, or are interested in an alternative to daily medications, you may be a candidate for the RADIANCE-HTN Clinical Study. The investigational study is evaluating a minimally-invasive, catheter-based procedure (the Paradise® Renal Denervation System) which may lower your blood pressure and reduce ...

Phase N/A

The purpose of the study is to examine the effectiveness and tolerability of a vaccine for C-diff infection in participants age 50 or older. This study is expected to last between 18 and 42 months and will require 5 office visits within the first 7 months. Participation includes 3 injections ...

Phase N/A

The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.

Phase

Obesity is a growing national health problem that now affects over 35% of Americans and is the leading cause of preventable death. Obesity affects all organ systems and contributes to the cause of a multitude of medical problems such as cardiovascular disease, diabetes and sleep apnea [1]. It is defined ...

Phase N/A

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Phase